Fusion glycoprotein F0

Fusion glycoprotein F0

Fusion glycoprotein F0 분자 정보

Molecule Name
Respiratory syncytial virus F protein
분자 별명
Fusion glycoprotein F0
Drug Development Progress
임상 약물 수5
시판 약물 수3
최고 연구 개발 단계Approved
표적 별명
Protein F,F,Fusion glycoprotein F0
분자 배경
The two surface glycoproteins of the mumps virus are the hemagglutinin-neuraminidase (HN) and Fusion proteins. These glycoproteins are essential for viral entry to host cells, and the spread of newly formed virions. The mumps fusion protein (F) is a 538-amino acid, class one fusion surface glycoprotein. It is responsible for the membrane fusion of virus and host cell. The un-cleaved protein has three hydrophobic regions: an amino-terminal signal peptide, an amino terminal region of F1 and the carboxyl-terminal membrane domain. This protein starts as a precursor molecule (F0), and is then cleaved into the active protein by the recognition of a R-X-L/R-R motif by a host endoprotease (furin). The F protein contains two disulfide-linked polypeptides (F1 and F2).

Fusion glycoprotein F0 제품 목록

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
CPI-RSV-F VaccineBLB-201Phase 2 ClinicalBlue Lake Biotechnology Inc
Respiratory Syncytial Virus Infections
상세
RSV vaccine (Vaxart)Phase 1 ClinicalVaxart Biosciences Inc
Respiratory Syncytial Virus Infections
상세
GR-2102GR2102; GR-2102Phase 1 ClinicalChongqing Genrix Biopharmaceutical Co Ltd, Genrix (Shanghai) Biopharmaceutical Co Ltd
Respiratory Syncytial Virus Infections
상세
Palivizumab biosimilar (mAbxience)MB-05Phase 1 ClinicalMabxience Sa
상세
RSM-01Phase 1 ClinicalBill & Melinda Gates Medical Research Institute
Respiratory Syncytial Virus Infections
상세

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
NirsevimabAnti-RSV-mAb-D25; SP-0232; MEDI-8897; Anti-RSV MAb-YTEApprovedAimm Therapeutics, MedImmune Inc, SanofiBeyfortus, 乐唯初EURespiratory Syncytial Virus InfectionsSanofi Winthrop Industrie SA2022-10-31
Lower Respiratory Tract Infections; Respiratory Syncytial Virus Infections
상세
PalivizumabABT-315; MEDI-493ApprovedAbbvie Inc, Medimmune LlcSynagisUnited StatesRespiratory Syncytial Virus InfectionsSwedish Orphan Biovitrum Ab (Publ)1998-06-19
Bronchiolitis; Bronchopulmonary Dysplasia; Heart Defects, Congenital; Infant, Premature, Diseases; Premature Birth; Respiratory Syncytial Virus Infections
상세
Respiratory syncytial virus immune globulinRSV-IGIVApprovedMedimmuneRespiGamUnited StatesRespiratory Syncytial Virus Infectionsnull1996-01-01
Respiratory Syncytial Virus Infections
상세